6-108074616-A-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The ENST00000193322.8(OSTM1):āc.36T>Gā(p.Cys12Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000085 in 1,412,368 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
ENST00000193322.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OSTM1 | NM_014028.4 | c.36T>G | p.Cys12Trp | missense_variant | 1/6 | ENST00000193322.8 | NP_054747.2 | |
OSTM1 | XM_047418679.1 | c.36T>G | p.Cys12Trp | missense_variant | 1/7 | XP_047274635.1 | ||
OSTM1 | XM_047418680.1 | c.36T>G | p.Cys12Trp | missense_variant | 1/6 | XP_047274636.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OSTM1 | ENST00000193322.8 | c.36T>G | p.Cys12Trp | missense_variant | 1/6 | 1 | NM_014028.4 | ENSP00000193322 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000602 AC: 1AN: 166138Hom.: 0 AF XY: 0.0000108 AC XY: 1AN XY: 92188
GnomAD4 exome AF: 0.00000850 AC: 12AN: 1412368Hom.: 0 Cov.: 32 AF XY: 0.00000858 AC XY: 6AN XY: 699648
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 06, 2022 | The c.36T>G (p.C12W) alteration is located in exon 1 (coding exon 1) of the OSTM1 gene. This alteration results from a T to G substitution at nucleotide position 36, causing the cysteine (C) at amino acid position 12 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 09, 2022 | This sequence change replaces cysteine, which is neutral and slightly polar, with tryptophan, which is neutral and slightly polar, at codon 12 of the OSTM1 protein (p.Cys12Trp). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with OSTM1-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at